Document Type : Case Study

Authors

1 Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

2 Faculty of Medical Sciences, Khatam Al-Nabieen University, Kabul, Afghanistan

3 Department of Epidemiology and Biostatics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran

10.55705/cmbr.2021.354911.1053

Abstract

Tuberculosis is a contagious infectious disease. This disease is called tuberculosis and is abbreviated as TB. Tuberculosis is one of the most important infectious diseases of this century, which can involve all the organs of the body, but the lungs are most affected by tuberculosis. The occurrence of 10 million new cases of tuberculosis and the treatment of only two-thirds of them, which unfortunately was incomplete in more than 50% of cases, shows the depth of the disaster in these years. The occurrence of three epidemics of this disease in the last two decades shows that the prospect of controlling tuberculosis soon is very uncertain. Today, more than 8 million people are infected with this disease in the world every year, and until now, one-third of the world's people have been infected with the germ of tuberculosis without feeling sick. Tuberculous peritonitis is an uncommon disorder; sometimes, it is not considered in the initial evaluation of ascites. A negative 5-TU PPD test, or a low level of ascitic fluid protein, can mistakenly divert attention from tuberculosis. Tuberculosis peritonitis can be fatal if not diagnosed in time. Here we report a 67-year-old patient who was confirmed to have tuberculous peritonitis after clinical examination and laboratory diagnosis. The patient recovered after diagnosis with prescribed drugs.

Graphical Abstract

Clinical analysis of diagnosing a case with tuberculous peritonitis from Afghanistan

Keywords

Main Subjects

Selected author of this article by journal

ِDr. Mahram Ali Mehran
Khatam Al-Nabieen University

ORCID

Open Access

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

 

Publisher’s Note

CMBR journal remains neutral with regard to jurisdictional claims in published maps and institutional afflictions.

 

Letters to Editor

Given that CMBR Journal's policy in accepting articles will be strict and will do its best to ensure that in addition to having the highest quality published articles, the published articles should have the least similarity (maximum 18%). Also, all the figures and tables in the article must be original and the copyright permission of images must be prepared by authors. However, some articles may have flaws and have passed the journal filter, which dear authors may find fault with. Therefore, the editor of the journal asks the authors, if they see an error in the published articles of the journal, to email the article information along with the documents to the journal office.

CMBR Journal welcomes letters to the editor (bfazel[email protected]) for the post-publication discussions and corrections which allows debate post publication on its site, through the Letters to Editor. Critical letters can be sent to the journal editor as soon as the article is online. Following points are to be considering before sending the letters (comments) to the editor.


[1] Letters that include statements of statistics, facts, research, or theories should include appropriate references, although more than three are discouraged.
[2] Letters that are personal attacks on an author rather than thoughtful criticism of the author’s ideas will not be considered for publication.
[3] There is no limit to the number of words in a letter.
[4] Letter writers should include a statement at the beginning of the letter stating that it is being submitted either for publication or not.

[5] Anonymous letters will not be considered.
[6] Letter writers must include Name, Email Address, Affiliation, mobile phone number, and Comments

[7] Letters will be answered as soon as possible

  1. Silva ML, Cá B, Osório NS, Rodrigues PN, Maceiras AR, Saraiva M (2022) Tuberculosis caused by Mycobacterium africanum: Knowns and unknowns. PLoS Pathogens 18(5):e1010490. doi:https://doi.org/10.1371/journal.ppat.1010490
  2. Coscolla M, Gagneux S, Menardo F, Loiseau C, Ruiz-Rodriguez P, Borrell S, Otchere ID, Asante-Poku A, Asare P, Sánchez-Busó L (2021) Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history. Microbial genomics 7(2):000477. doi:https://doi.org/10.1099%2Fmgen.0.000477
  3. Baray F, Noori MB, Aram MM, Hamidi H (2022) Misdiagnosis of Budd Chiari syndrome, a case report from Afghanistan. Annals of Medicine and Surgery 73:103218. doi:https://doi.org/10.1016/j.amsu.2021.103218
  4. Liu R, Li J, Tan Y, Shang Y, Li Y, Su B, Shu W, Pang Y, Gao M, Ma L (2020) Multicenter evaluation of the acid-fast bacillus smear, mycobacterial culture, Xpert MTB/RIF assay, and adenosine deaminase for the diagnosis of tuberculous peritonitis in China. International Journal of Infectious Diseases 90:119-124. doi:https://doi.org/10.1016/j.ijid.2019.10.036
  5. Zetola NM, Shin SS, Tumedi KA, Moeti K, Ncube R, Nicol M, Collman RG, Klausner JD, Modongo C (2014) Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes. Journal of Clinical Microbiology 52(7):2422-2429. doi:https://doi.org/10.1128/JCM.02489-13
  6. Luo Y, Xue Y, Mao L, Lin Q, Tang G, Song H, Wang F, Sun Z (2020) Diagnostic value of T-SPOT. TB assay for tuberculous peritonitis: a meta-analysis. Frontiers in medicine 7:585180. doi:https://doi.org/10.3389/fmed.2020.585180
  7. Kumabe A, Hatakeyama S, Kanda N, Yamamoto Y, Matsumura M (2020) Utility of Ascitic fluid adenosine deaminase levels in the diagnosis of tuberculous peritonitis in general medical practice. Canadian Journal of Infectious Diseases and Medical Microbiology 2020:Article ID: 5792937. doi:https://doi.org/10.1155/2020/5792937
  8. Ionescu S, Nicolescu AC, Madge OL, Marincas M, Radu M, Simion L (2021) Differential Diagnosis of Abdominal Tuberculosis in the Adult—Literature Review. Diagnostics 11(12):2362. doi:https://doi.org/10.3390/diagnostics11122362
  9. Yu Y (2020) IDDF2020-ABS-0050 Spiral CT in the clinical significance of portal cavernous change in hepatocellular carcinoma. Gut 69(Suppl 2):A1–A95. doi:http://dx.doi.org/10.1136/gutjnl-2020-IDDF.136
  10. Coulier B, Montfort L, Doyen V, Gielen I (2010) MDCT findings in primary amyloidosis of the greater omentum and mesentery: a case report. Abdominal imaging 35(1):88-91. doi:https://doi.org/10.1007/s00261-008-9487-2
  11. Zhang F, Xu C, Ning L, Hu F, Shan G, Chen H, Yang M, Chen W, Yu J, Xu G (2016) Exploration of serum proteomic profiling and diagnostic model that differentiate Crohn's disease and intestinal tuberculosis. PloS one 11(12):e0167109. doi:https://doi.org/10.1371/journal.pone.0167109
  12. Chester C, Dorigo O, Berek JS, Kohrt H (2015) Immunotherapeutic approaches to ovarian cancer treatment. Journal for immunotherapy of cancer 3(1):1-10. doi:https://doi.org/10.1186/s40425-015-0051-7
  13. Huang X, Liao W-D, Yu C, Tu Y, Pan X-L, Chen Y-X, Lv N-H, Zhu X (2015) Differences in clinical features of Crohn's disease and intestinal tuberculosis. World journal of gastroenterology: WJG 21(12):3650. doi:https://doi.org/10.3748%2Fwjg.v21.i12.3650
  14. Zhang J, Bao Y (2022) Value of MSCT plus MRI in the Detection of Colon Cancer. Evidence-Based Complementary and Alternative Medicine 2022:Article ID: 6507865. doi:https://doi.org/10.1155/2022/6507865
  15. Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, Meccugni B, Dori IM, Andreani A, Bergamini BM (2006) Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. The Lancet 367(9519):1328-1334. doi:https://doi.org/10.1016/S0140-6736(06)68579-6